BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Jessica Fye does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 MRNAModerna Inc | Sell | $26.00 | May 2025 | −61.5% | Hit |
 BCRXBioCryst Pharmaceuticals Inc | Buy | $13.00 | May 2025 | −21.7% | Miss |
 IMCRImmunocore Holdings Ltd | Buy | $50.00 | Apr 2025 | +6.0% | Miss |
 MBXMBX Biosciences, Inc. Common Stock | Buy | $30.00 | Oct 2024 | −27.2% | Miss |
| MRNAModerna Inc | Sell | $70.00 | Sep 2024 | +54.0% | Hit |
 ONCBeiGene, Ltd. | Buy | $186.00 | Mar 2024 | +54.7% | Hit |
| ONCBeiGene, Ltd. | Buy | $185.00 | Feb 2024 | +49.6% | Hit |
 EBSEmergent Biosolutions Inc | Sell | — | Nov 2023 | −285.2% | — |
 AMRNAmarin Corporation PLC | Sell | — | Nov 2023 | +46.9% | — |
 NKTRNektar Therapeutics | Sell | — | Nov 2023 | −108.6% | — |
 INSMInsmed Inc | Buy | $36.00 | Nov 2023 | +192.0% | Hit |
 MIRMMirum Pharmaceuticals Inc | Buy | $37.00 | Nov 2023 | +21.0% | Hit |
 CRNXCrinetics Pharmaceuticals Inc | Buy | $35.00 | Nov 2023 | +73.8% | Hit |
| IMCRImmunocore Holdings Ltd | Buy | $60.00 | Nov 2023 | −38.4% | Hit |
 DNLIDenali Therapeutics Inc | Buy | $28.00 | Nov 2023 | +23.2% | Hit |
| BCRXBioCryst Pharmaceuticals Inc | Buy | $10.00 | Nov 2023 | +30.9% | Miss |
| EBSEmergent Biosolutions Inc | Sell | $9.00 | Mar 2023 | +85.3% | Hit |
 TVRDTvardi Therapeutics, Inc. | Buy | $20.00 | Mar 2022 | −47.6% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.